160 related articles for article (PubMed ID: 23504108)
1. Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.
Cintolo JA; Tchou J; Pryma DA
Breast Cancer Res Treat; 2013 Apr; 138(2):331-46. PubMed ID: 23504108
[TBL] [Abstract][Full Text] [Related]
2. Role of positron emission tomography/computed tomography in breast cancer.
Bourgeois AC; Warren LA; Chang TT; Embry S; Hudson K; Bradley YC
Radiol Clin North Am; 2013 Sep; 51(5):781-98. PubMed ID: 24010906
[TBL] [Abstract][Full Text] [Related]
3. Evolving role of positron emission tomography in breast cancer imaging.
Eubank WB; Mankoff DA
Semin Nucl Med; 2005 Apr; 35(2):84-99. PubMed ID: 15765372
[TBL] [Abstract][Full Text] [Related]
4. [Positron emission tomography in breast cancer].
Richter JA; García-Velloso MJ; Domínguez I; Quincoces G; Prieto E; Rodríguez Fraile M
Rev Med Univ Navarra; 2008; 52(1):4-12. PubMed ID: 18578191
[TBL] [Abstract][Full Text] [Related]
5. F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging.
Avril N; Adler LP
Radiol Clin North Am; 2007 Jul; 45(4):645-57, vi. PubMed ID: 17706529
[TBL] [Abstract][Full Text] [Related]
6. Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography.
Bénard F; Turcotte E
Breast Cancer Res; 2005; 7(4):153-62. PubMed ID: 15987467
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.
Alberini JL; Lerebours F; Wartski M; Fourme E; Le Stanc E; Gontier E; Madar O; Cherel P; Pecking AP
Cancer; 2009 Nov; 115(21):5038-47. PubMed ID: 19645022
[TBL] [Abstract][Full Text] [Related]
8. Role of positron-emission tomography scan in the diagnosis and management of breast cancer.
Almubarak M; Osman S; Marano G; Abraham J
Oncology (Williston Park); 2009 Mar; 23(3):255-61. PubMed ID: 19418826
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer.
Bernsdorf M; Graff J
Clin Physiol Funct Imaging; 2014 Nov; 34(6):426-33. PubMed ID: 24267489
[TBL] [Abstract][Full Text] [Related]
10. PET Imaging of Breast Cancer: Role in Patient Management.
Lebron L; Greenspan D; Pandit-Taskar N
PET Clin; 2015 Apr; 10(2):159-95. PubMed ID: 25829085
[TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose-PET in the management of breast cancer.
Kumar R; Alavi A
Radiol Clin North Am; 2004 Nov; 42(6):1113-22, ix. PubMed ID: 15488561
[TBL] [Abstract][Full Text] [Related]
12. PET imaging in breast cancer.
Bombardieri E; Crippa F
Q J Nucl Med; 2001 Sep; 45(3):245-56. PubMed ID: 11788817
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for positron emission tomography in breast cancer staging?
Hodgson NC; Gulenchyn KY
J Clin Oncol; 2008 Feb; 26(5):712-20. PubMed ID: 18258978
[TBL] [Abstract][Full Text] [Related]
14. FDG PET, PET/CT, and breast cancer imaging.
Rosen EL; Eubank WB; Mankoff DA
Radiographics; 2007 Oct; 27 Suppl 1():S215-29. PubMed ID: 18180228
[TBL] [Abstract][Full Text] [Related]
15. The value of 18-FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan.
Garami Z; Hascsi Z; Varga J; Dinya T; Tanyi M; Garai I; Damjanovich L; Galuska L
Eur J Surg Oncol; 2012 Jan; 38(1):31-7. PubMed ID: 21937190
[TBL] [Abstract][Full Text] [Related]
16. [PET/CT in breast cancer: an update].
Groheux D; Moretti JL; Giacchetti S; Hindié E; Teyton P; Cuvier C; Bousquet G; Misset JL; Boin C; Espié M
Bull Cancer; 2009 Nov; 96(11):1053-70. PubMed ID: 19758959
[TBL] [Abstract][Full Text] [Related]
17. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
18. Clinical molecular imaging with positron emission tomography.
Saleem A; Charnley N; Price P
Eur J Cancer; 2006 Aug; 42(12):1720-7. PubMed ID: 16797972
[TBL] [Abstract][Full Text] [Related]
19. [Positron emission tomography (PET) in diagnosis of breast carcinoma].
Ivancevic V
Zentralbl Chir; 1998; 123 Suppl 5():53-6. PubMed ID: 10063574
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer.
Kim BS; Sung SH
Ann Nucl Med; 2012 Feb; 26(2):175-83. PubMed ID: 22139552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
